Neuriva Side Effects: What the 42-Day Trial and User Reports Actually Show
Neuriva’s controlled safety data cover 42 days in 138 healthy adults, with no serious adverse events reported. User reports add headache, stomach upset, insomnia and dry mouth. The long-term record is thin, and the label itself excludes pregnant women, children and people with medical conditions unless a doctor clears it. RecallPath Editorial Team separated what is documented from what is merely claimed, with sources for each line.
Written and fact-checked by RecallPath Editorial Team. Last updated: . About our editorial process.
- What is inside: 100 mg whole coffee cherry extract plus 100 mg soy-derived phosphatidylserine (Neuriva Original), with under 4 mg of caffeine per dose (Pharmacy Times).
- Trial record: 138 adults aged 40-65, 42 days, one capsule daily: well tolerated, no serious adverse events (Doma et al., 2023).
- User-reported: headache, stomach upset or irritation, insomnia, dry mouth. Reported means observed, not proven caused.
- Theoretical flag: phosphatidylserine may interact with cholinergic and anticholinergic drugs (Pharmacy Times).
- Label exclusions: under 18, pregnancy and breastfeeding, and anyone with a medical condition, unless a physician agrees.
What Neuriva contains
Neuriva is made by Schiff Vitamins, part of Reckitt, and launched in the United States in April 2019. The Original formula has exactly two active ingredients.
The Plus, Ultra and 3D variants add B vitamins and, in some versions, plant-sourced PS at higher amounts. None of the variants has its own published safety study. Everything documented below comes from the Original formula’s trial and from ingredient-level references.
The trial safety record: solid for 42 days, silent beyond
Doma et al., 2023: the one Neuriva safety dataset
Design. Randomized, double-blind, placebo-controlled, parallel study. 138 healthy adults aged 40 to 65 with self-reported memory problems. One capsule daily, morning, with or without food, for 42 days.
Safety result. The formulation was well tolerated, and no serious adverse events were reported. This is the strongest safety statement that exists for Neuriva, and its ceiling is day 42.
Ingredient-level context. Phosphatidylserine has been used safely at up to 300 mg daily for up to 6 months in studies (Pharmacy Times). Safety data on whole coffee cherry extract are limited, though it carried a GRAS notice and was well tolerated in trials, with negligible caffeine.
Pharmacy Times’ bottom line: there is a lack of data on Neuriva’s long-term safety, particularly in people with pre-existing conditions.
The reported side effect list
No controlled trial has published incidence rates for Neuriva side effects. What exists is a consistent pattern across user-facing references and reviews:
- Headache. The most frequently named complaint across user reports.
- Stomach upset or irritation. Includes nausea-type complaints; often described as mild and short-lived as the body adjusts.
- Insomnia. Reported often enough to matter; see the caffeine section below for the likely mechanism.
- Dry mouth. Less common, but repeatedly mentioned.
Read “reported” literally: these events occurred while people took Neuriva, and no published source proves causation. If a symptom persists after stopping, that conversation belongs with a doctor, not a review section.
The caffeine question: decaffeinated is not zero
Under 4 mg per dose, but sensitivity is individual
Schiff markets the coffee fruit extract as caffeine-free. Pharmacy Times puts the residual content at under 4 mg per dose. For comparison, a cup of drip coffee runs 80 to 100 mg. For most people that trace is irrelevant. For the caffeine-sensitive, even small amounts can mean restlessness, a faster heartbeat, trouble sleeping or stomach irritation. If you react to decaf coffee, treat Neuriva the same way: take it in the morning or not at all.
Interactions and the label’s own exclusions
Drug interaction theory. Phosphatidylserine may increase acetylcholine levels, which means it could in theory interfere with anticholinergic drugs and add to cholinergic ones (Pharmacy Times). No documented case study proves this in Neuriva users. The fix is the same five-minute conversation: bring the label to your doctor or pharmacist.
The label’s exclusion list. Per Pharmacy Times’ review of the product label: children under 18, pregnant or breastfeeding women, and people with medical conditions should not take Neuriva without consulting a physician first. That is the manufacturer talking, not us.
The claims settlement you should know about
A 2020 class action over “clinically proven”
In 2020, buyers sued Reckitt Benckiser over Neuriva’s “clinically proven to fuel brain performance” marketing, arguing the two active ingredients lacked valid scientific proof. The case settled for a reported $8 million, with changes to marketing practices and consumer compensation, according to Top Class Actions’ settlement coverage. The safety question and the claims question are separate. This section is about the second one.
The bottom line
Neuriva’s 42-day safety record is clean, its reported side effects are the classic mild trio plus dry mouth, and its residual caffeine is trace-level. What it lacks is long-term data, variant-level data and documented interaction evidence. That profile suits a healthy adult running a 42-day personal trial with eyes open. It does not suit pregnancy, polypharmacy or a memory problem that is getting worse. For the label check after 60, see our Neuriva review; for the ingredient behind the interaction theory, our phosphatidylserine guide covers the dose evidence.
Frequently Asked Questions
Does Neuriva have side effects?
Possibly mild ones. In the 42-day controlled study of 138 adults, the formula was well tolerated with no serious adverse events. User reports name headache, stomach upset, insomnia and dry mouth. No incidence rates are published, and causation is unproven.
What are the side effects of Neuriva?
The reported list: headache, stomach upset or irritation, insomnia and dry mouth. Caffeine-sensitive users may add restlessness, faster heartbeat and stomach irritation from the trace caffeine (under 4 mg per dose) in the coffee fruit extract. Persistent symptoms after stopping warrant a doctor visit.
Does Neuriva have caffeine?
A trace amount. Schiff markets the coffee fruit extract as caffeine-free, and Pharmacy Times reports under 4 mg of caffeine per dose, versus 80 to 100 mg in a cup of drip coffee. For most people this is negligible; caffeine-sensitive individuals should still take Neuriva in the morning.
Can Neuriva raise blood pressure?
No documented case exists. The theoretical path is caffeine: the coffee fruit extract carries under 4 mg per dose, too little to affect most people, but sensitive individuals have reported a faster heartbeat and related symptoms. If you take blood pressure medication, clear Neuriva with your doctor first, as you would with any supplement.
Are there different side effects for women?
No gender-specific data exist. The 42-day trial included 47 women in the Neuriva arm and reported no serious adverse events for the group, but the study was not designed to detect sex differences. Pregnancy and breastfeeding are different: the label advises against use, and the safe default is to skip it.
Do Neuriva Plus, Ultra or 3D have different side effects?
Unknown. No variant has its own published safety study; the 42-day data cover the Original formula. The added B vitamins in Plus and Ultra sit near nutritional doses, and phosphatidylserine remains at studied levels. Treat every variant like the Original until variant-specific data exist.
Who should not take Neuriva?
Per the product label, reviewed by Pharmacy Times: children under 18, pregnant or breastfeeding women, and people with medical conditions should not take Neuriva without consulting a physician. Anyone on cholinergic or anticholinergic medication should also clear it first, because phosphatidylserine may interact with those drug classes in theory.
Is Neuriva safe for long-term use?
Unverified. The controlled safety record ends at day 42. Phosphatidylserine separately has a 6-month safety record at doses up to 300 mg daily, and whole coffee cherry extract has a GRAS notice, but Neuriva as a product has no long-term study. Pharmacy Times flags the lack of long-term data as the main safety gap.
Sources and References
- Neuriva: A Closer Look at the Efficacy and Safety of This Popular Supplement – Pharmacy Times, 2025
- Doma et al. – Randomized, double-blind, placebo-controlled study of Neuriva, 42 days – 2023
- Neuriva vs Prevagen: side effect comparison – BuzzRx, 2025
- What Are the Side Effects of Neuriva? – Discover Magazine, 2023
- Neuriva false-ad class action and settlement coverage – Top Class Actions, 2020
- Neuriva ingredients – Schiff Vitamins official page
Need help choosing?
RecallPath does not sell supplements. We publish facts for readers over 40.
Email us